Group A Streptococcus (GAS) is a formidable human pathogen responsible for a wide range of clinical syndromes, from mild pharyngitis and pyoderma to life‐threatening invasive diseases and ...

Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as ...

Investigators in Canada have discovered that molecular changes to an infectious bacterium (Group A Streptococcus pyogenes [GAS]) underlie a post-pandemic surge of coinfections with a respiratory ...

There was an increase seen in incidence from 3.6 to 8.2 per 100,000 persons from 2013 to 2022. T HealthDay News — During 2013 to 2022, there was an increase in invasive group A Streptococcus (GAS) ...

Researchers have discovered the novel mechanism that underlies a previously reported observation that infection by group A Streptococcus bacteria reduces the risk of later developing Type 1 diabetes.

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s ...

Strep infections are most well known for causing strep throat, which can be treated with antibiotics. But this type of bacteria can also cause more serious illnesses—even flesh-eating infections. The ...

About GAS Group A Streptococcus (GAS) can cause a wide range of conditions ranging from life-threatening to mild depending on the severity of infection. Invasive GAS infections can cause diseases like ...